Vascularization is still one of the most important limitations for the survival of engineered tissues after implantation. In this study, we aim to improve the in vivo vascularization of engineered adipose tissue by preforming vascular structures within in vitro-engineered adipose tissue constructs that can integrate with the host vascular system upon implantation. Different cell culture media were tested and different amounts of human adipose tissue-derived mesenchymal stromal cells (ASC) and human umbilical vein endothelial cells (HUVEC) were combined in spheroid cocultures to obtain optimal conditions for the generation of prevascularized adipose tissue constructs. Immunohistochemistry revealed that prevascular structures were formed in the constructs only when 20% ASC and 80% HUVEC were combined and cultured in a 1:1 mixture of endothelial cell medium and adipogenic medium. Moreover, the ASC in these constructs accumulated lipid and expressed the adipocyte-specific gene fatty acid binding protein-4. Implantation of prevascularized ASC/HUVEC constructs in nude mice resulted in a significantly higher amount of vessels (37 ± 17 vessels/mm 2 ) within the constructs compared to non-prevascularized constructs composed only of ASC (3 ± 4 vessels/mm 2 ). Moreover, a subset of the preformed human vascular structures (3.6 ± 4.2 structures/mm 2 ) anastomosed with the mouse vasculature as indicated by the presence of intravascular red blood cells. Our results indicate that preformed vascular structures within in vitro-engineered adipose tissue constructs can integrate with the host vascular system and improve the vascularization upon implantation.
INTRODUCTION
engineered adipose tissue construct can take several days (10) , which is too slow and fatal for many of the cells in the construct. A sufficiently rapid in vivo vascu-Despite various levels of clinical success, currently used surgical procedures to repair soft tissue defects are larization, preventing cell death in the core of the implanted engineered adipose tissue constructs, has not not optimal. Autologous adipose tissue grafts suffer from donor site morbidity (26) and have a tendency to been realized yet. We and others have shown that endothelial cells (EC) lose volume over time (24, 25, 29) . Synthetic implants also have significant drawbacks such as infection, rejec-cocultured with stromal cells derived from bone marrow, skin, cardiac muscle, skeletal muscle, or adipose tion, leakage, and/or dislocation (29) .
The in vitro development of autologous adipose tis-tissue can form primitive vascular-like structures in vitro (2, 3, 5, 9, 14, 23, 27, 31, 34) . Few studies also indicate that sue substitutes using human adipose tissue-derived mesenchymal stromal cells (ASC) may offer a future alter-such in vitro preformed vascular-like structures (or prevascular structures) are able to connect to the host vessels native to these current treatments (1, 4, 7, 8, 11) . However, limited survival of in vitro-engineered adipose tissue after implantation (21, 23, 27, 31) . The ability of prevascular structures to promote the in vivo vascularization of after in vivo implantation is still a major hurdle for clinical use (12, 26) . The reason for this limited survival is engineered adipose tissue constructs, however, has not been tested yet. that ingrowth of blood vessels from the host into the 1008 VERSEIJDEN ET AL.
In this study, we generate prevascularized adipose tis-dexamethasone, 0.01 mg/ml insulin (Eli Lilly, Houten, The Netherlands), 0.2 mM indomethacin (Sigma-Aldrich), sue constructs using three-dimensional (3D) spheroids (about 0.6 mm in diameter) containing cocultured ASC 0.5 mM 3-isobutyl-I-methyl-xanthine (Sigma-Aldrich), 1% penicillin/streptomycin, and 0.5% gentamycin; 3) 1:1 and endothelial cells (EC) and test this hypothesis. Specifically, we investigated the following questions: (1) mixture of endothelial cell medium and adipogenic medium (endothelial/adipogenic mix medium). The culture Can we induce in vitro prevascularization of the 3D spheroid HUVEC/ASC constructs while simultaneously media were refreshed every 3 days and cell numbers of duplicate wells were counted twice with a Casy cell enabling adipogenic differentiation of the ASC? (2) Can the in vitro-generated prevascular structures integrate counter (Innovatis, Bielefeld, Germany) at 0, 3, 7, and 10 days of culture. with the host vasculature?
MATERIALS AND METHODS

Formation of Spheroids Cell Culture
Spheroids containing only ASC or ASC with different amounts of HUVEC (5% HUVEC/95% ASC, 20% Subcutaneous abdominal adipose tissue was obtained HUVEC/80% ASC, 40% HUVEC/60% ASC, and 80% from donors with approval of the Medical Ethical Com-HUVEC/20% ASC) were prepared in 10-ml polypropylmittee (# MEC-2005-157). ASC from three different doene tubes (Techno Plastic Products, Trasadingen, Switnors of 47, 54, and 59 years of age were isolated from zerland) in 0.5-ml endothelial cell medium. ASC or the adipose tissue as previously described (33) and HUVEC/ASC suspensions containing a total of 2.5 × grown on basal medium [Dulbecco's modified Eagle 10 5 cells were added to the tubes and subsequently cenmedium 1 g/L glucose (Invitrogen, Carlsbad, CA), 10% trifuged at 150 × g for 5 min. The tubes with the result-FCS (PAA Laboratories, Pasching, Austria), 10 −12 M ing cell pellets were then incubated overnight at 37°C dexamethasone, 10 −5 M ascorbic acid (both from Sigmawith 5% CO 2 in a humidified atmosphere to allow the Aldrich, St. Louis, MO), 1% penicillin/streptomycin, formation of spheroids. After overnight incubation, the 0.5% gentamycin (both from Invitrogen)]. endothelial cell medium of the ASC/HUVEC coculture Commercially derived pooled human umbilical vein spheroids was replaced by endothelial/adipogenic mix endothelial cells (HUVEC) (Lonza, Verviers, Belgium) medium, and in ASC spheroids by endothelial/adipowere cultured in endothelial growth medium consisting genic mix medium or adipogenic medium. Medium was of human endothelial serum-free medium (Invitrogen), replenished every 2 days. supplemented with 20% FCS, 10% human serum (PAA Laboratories), 20 ng/ml fibroblast growth factor 2 (FGF-Flow Cytometric Analysis of Coculture Spheroids 2), and 100 ng/ml epidermal growth factor (EGF) (both Following 2, 7, and 14 days of culture, HUVEC/ASC from Peprotech EC, London, UK). Cells were maincoculture spheroids were harvested for flow cytometric tained at 37°C in a humidified atmosphere with 5% CO 2 , analysis. To obtain a single cell suspension, spheroids and the medium was replenished every 3 days. Passage were washed twice with PBS and digested in a sterile-2 ASC and passage 5 or less HUVEC were used in this filtered collagenase type I solution (1000 U/ml in PBS) study.
for 20 min at 37°C. After digestion, cell suspensions Medium Selection: Proliferation of ASC and HUVEC were washed with FACS buffer [Hanks' balanced salt in Different Media solution (Invitrogen), 2% BSA, 0.05% sodium azide (both from Sigma-Aldrich), and 2% heat-inactivated hu-The proliferation of ASC and HUVEC in different media was tested in six-well (ASC) and 24-well (HUVEC) man serum (PAA Laboratories)] and labeled for 30 min on ice in the dark with mouse anti-human CD31 fluores-plates (Costar, Corning Inc., Corning, NY) seeded with 1042 and 5000 cells/cm 2 , respectively. ASC and cently labeled antibody [dilution 1:1 in FACS buffer, BD Biosciences Pharmingen (Cat. No. 555446), Erem-HUVEC were seeded onto the culture plates in basal medium and endothelial growth medium respectively bodegem, Belgium]. Cells were washed again, resuspended in 300 µl of FACS buffer, and directly analyzed and incubated overnight at 37°C in a humid atmosphere with 5% CO 2 to ensure attachment of the cells. The next on a FACS-Calibur instrument (Becton-Dickinson Biosciences, Franklin Lakes, NJ). day, these media were removed and the cells were washed with PBS and replenished with three different RNA Isolation, Complementary DNA (cDNA) Synthesis, test media: 1) endothelial cell medium consisting of enand Quantitative Polymerase Chain Reaction (Q-PCR) dothelial serum-free medium supplemented with 5% FCS, 20 ng/ml FGF-2, and 100 ng/ml EGF; 2) adipo-ASC spheroids were cultured in endothelial/adipogenic mix medium or adipogenic medium for 7 days in genic medium consisting of Dulbecco's modified Eagle medium 4.5 g/L glucose (Invitrogen), 10% FCS, 1 µM vitro. Six spheroids were prepared from each ASC do-nor, and three pools of two spheroids from each donor sue-Tek (Sakura, Finetek Europe, Zoeterwoude, The Netherlands) and snap frozen. were used for RNA isolation. The spheroids were fragmented with a pestle on ice and sheared using an insulin Paraffin-embedded sections (5 µm) were deparaffinized and rehydrated. Cryosections (5 µm) were fixed syringe.
Total RNA was extracted from ASC spheroids using with 3.7% formalin in deionised water for 1 h. Qiazol Lysis Reagent (Qiagen, Venlo, The Netherlands).
CD31 Staining of In Vitro Cultured Spheroids RNA was further purified using the RNeasy Micro Kit
To determine HUVEC organization in spheroid cul- ( To distinguish human tissue from mouse tissue and to determine the number and relative area occupied by In Vivo Implantation human vascular structures in construct sections postim-Four spheroids consisting of ASC and four spheroids plantation, monoclonal mouse anti-human vimentin anticonsisting of 80% HUVEC/20% ASC were created from body [Clone V9, 1:40 dilution in PBS/1% BSA, Sigmaeach of the three donors, resulting in a total of 12 ASC Aldrich (Cat. No. V6630)], and monoclonal mouse antispheroids and 12 80% HUVEC/20% ASC spheroids.
human CD31 antibody (Dako) were used, respectively. After 7 days of in vitro culture, the spheroids were im-To reduce unspecific binding of the secondary goat antiplanted subcutaneously in the left and right scapular area mouse antibody (Dako) to mouse IgGs, the mouse-on of six 9-week-old athymic male nude mice (NMRI-nu/ mouse HRP-Polymer Kit (Biocare Medical, Concord, nu, Taconic, Hudson, NY). The mice were placed under CA) was used, according to the manufacturer's instrucgeneral anesthesia with 2.5% isoflurane after which two tions with some slight modifications. In short, antigen separate 0.5-cm incisions were made through the dorsal retrieval was performed through incubation in Rodent skin. Next, two separate subcutaneous pockets were pre-Decloaker (Biocare Medical) for 60 min at 95°C. Nonpared by blunt dissection of the subcutaneous tissue. specific binding sites were blocked with Rodent Block One pocket was filled with two ASC spheroids and the M (Biocare Medical) and sections were stained overother pocket was filled with two 80% HUVEC/20% night with CD31 or vimentin at 4°C. The MM-polymer-ASC spheroids. Pockets were closed with discontinuous HRP secondary antibody (Biocare Medical) was used, sutures using Mersilk 5-0 (Ethicon, Somerville, NJ). The followed by incubation in diaminobenzidine (Sigmacontent of each pocket was regarded as one construct.
Aldrich) to visualize CD31 or vimentin expression, re-Seven days after implantation, the mice were sacrispectively. The slides were weakly counterstained with ficed and the constructs retrieved. All procedures were hematoxylin, dehydrated through graded alcohols, and approved by the animal ethical committee (EUR. 1292).
mounted with Permount (VWR International B.V., Amsterdam, The Netherlands).
Histology
Oil Red O Staining Constructs harvested 7 days after culture or 7 days after implantation were fixed in 10% formalin in PBS Accumulated lipid in ASC in spheroids was detected after 7 days of in vitro culture and after 7 days of im-and embedded in paraffin, or directly embedded in Tis-plantation. In short, a 0.5% (w/v) stock solution of Oil shown), indicating that endothelial/adipogenic mix medium had a more positive effect on the adipogenic dif-Red O in triethyl-phosphate (Sigma-Aldrich) was diluted 3:2 with deionized water to prepare an Oil Red O ferentiation of ASC. Because endothelial/adipogenic mix medium supported both ASC and HUVEC prolifer-working solution. Subsequently, cryosections were fixed, rinsed, and immersed in Oil Red O working solu-ation and was more likely to support ASC adipogenic differentiation than endothelial cell medium, subsequent tion for 30 min. Hereafter, sections were washed with deionized water and counterstained with hematoxylin coculture experiments were conducted in endothelial/adipogenic mix medium. for 1 min. Finally, sections were rinsed with running tap water for 10 min, and covered with Imsolmount (Klini-Formation of Spheroids path, Zevenaar, The Netherlands).
Following the described method, ASC and HUVEC/ Histomorphometry ASC cocultures formed solid 3D spheroids with a diam-High resolution (0.23 µm/pixel), low magnification eter of 0.63 ± 0.12 mm. These spheroids were stable (40×) digital micrographs covering two to three comduring the total subsequent culture period of 14 days. plete vimentin/CD31 immunostained cross sections of Flow Cytometric Analyses of CD31-Positive each construct were made with a Nanozoomer HT (Ha-Cells in HUVEC/ASC Spheroid Cocultures mamatsu Photonics, Hamamatsu City, Japan) for analysis. Subsequently, NIH ImageJ software (http://rsb.info.
To determine whether the amount of HUVEC seeded nih.gov/ij/) was used to count the number of CD31 + prein the spheroid cocultures remained stable during culture vascular structures, the area occupied by these strucwe determined the percentage of CD31 + cells in the cotures, and the complete area of human tissue in the conculture spheroids after 2, 7, and 14 days of culture using structs.
flow cytometric analysis. The percentage of CD31 + cells decreased in all spheroids during culture ( Fig. 2A) . Es-Statistical Analysis pecially between days 2 and 7 there was a significant All data are expressed as mean ± SD, except a part decline in the percentage of CD31 + cells in almost all of the in vivo vascularization data, which are expressed spheroids. However, after 14 days of culture all spheras median (IQR). The FACS data were analyzed with oids still contained CD31 + cells, with the spheroids the mixed model analysis of variance using SAS softseeded with 80% of HUVEC still containing almost ware (SAS Insitute, Cary, NC). The FABP4 expression 25% of CD31 + cells. This percentage decreased with dedata were analyzed with the unpaired t-test with Welch creasing HUVEC seeding densities ( Fig. 2A-E ). Sphercorrection using Graphpad Prism 5.01 software (Graphoids containing no HUVEC also contained a small perpad Software, San Diego, CA). Differences in the numcentage (0.77-3.21%) of CD31 + cells. ber of (mouse) vascular lumens per cross-sectional area HUVEC Organization in HUVEC/ASC between prevascularized and nonprevascularized con-Spheroid Cocultures structs were analyzed with the nonparametric Mann-Whitney test using Graphpad Prism 5.01 software. Val-After 7 days of culture in endothelial/adipogenic mix ues with p ≤ 0.05 were considered significant. medium, cross sections of spheroid cocultures were stained with CD31 to determine endothelial organiza-RESULTS tion. CD31 + cells in ASC spheroids seeded with 5%, HUVEC and ASC Proliferation in Different Media 20%, and 40% HUVEC were present as round cell clusters dispersed throughout the spheroids (Fig. 3A-C) . To find the appropriate culture conditions for our HUVEC/ASC spheroid cocultures we determined the In ASC spheroids seeded with 80% HUVEC, however, the CD31 + endothelial cells aligned and formed proliferation potential of both ASC and HUVEC in three different media: endothelial cell medium, adipogenic prevascular structures amidst the ASC (Fig. 3D ). This endothelial organization was observed in spheroids of medium, and endothelial/adipogenic mix medium.
ASC and HUVEC proliferated on both endothelial all three donors. Although HUVEC aligned and formed loops, no lumen formation was observed. cell medium and endothelial/adipogenic mix medium, while neither cell type proliferated in adipogenic me-Adipogenic Differentiation of ASC in Spheroid dium (Fig. 1 
). ASC and HUVEC proliferation was
Cultures In Vitro higher on endothelial cell medium than on endothelial/ adipogenic mix medium. However, ASC had a more
To assess adipogenic differentiation of the ASC in the spheroids, we measured the expression of the adipo-spindle-like morphology and accumulated no lipid on endothelial cell medium when compared to the ASC cul-genic marker FABP4 in ASC spheroids after 7 days of culture. Q-PCR analysis showed that FABP4 is ex-tured in endothelial/adipogenic mix medium (data not pressed by ASC in spheroids cultured in endothelial/adi-Assessment of Human Vascular Structures in HUVEC/ ASC Spheroids Following Implantation in Nude Mice pogenic mix medium, albeit significantly lower than in the ASC cultured in adipogenic medium (Fig. 4A) .
To further characterize adipogenic differentiation, we Following 7 days of culture, the prevascularized 80% HUVEC/20% ASC spheroids and non-prevascularized evaluated the ability of ASC to accumulate lipid after 7 days of culture in endothelial/adipogenic mix medium.
ASC spheroids were implanted subcutaneously in nude mice, in order to determine if preformed human vascular Oil Red O staining showed that Oil Red O-positive cells were evident in these ASC spheroid cultures (Fig. 4B) .
structures were able to promote in vivo vascularization. After 7 days the spheroid constructs were retrieved. CD31 + cells per cross section. The number of human vascular lumens per cross section ranged from 13 to 45 Gross examination revealed that the constructs still had a spherical shape and were invaded by vessels ( Fig. 5 ).
lumens/mm 2 (average 23 ± 15 lumens/mm 2 ) with a lumen density that ranged from 0.1% to 4.5% (average 1.8 ± To determine whether human vascular structures were present inside the retrieved constructs, we per-2.0%) and a human CD31 + cell density of 6.9 ± 4.5%. The number of human vascular lumens and the lumen formed immunostaining with anti-human CD31. Cross sections of the retrieved spheroid constructs showed that density were variable in cross sections of different spheroid constructs of the same ASC donor as well as none of the ASC spheroid constructs and four out of the six 80% HUVEC /20% ASC spheroid constructs con-between ASC donors. Importantly, the human CD31 + vascular structures tained human CD31 + structures. To provide insight in the vascularization of the constructs, we measured three showed an increased organization when compared to the constructs prior to implantation (compare Fig. 3D with parameters: 1) the number and 2) density of vascular lumens of human origin and 3) the percentage of human human vascular lumens (3.6 ± 4.2 lumens/mm 2 ) with a vascular lumens (lumens not stained with CD31 plus the CD31 + lumens) per tissue section were also evaluated lumen density of 1.0 ± 1.1% was filled with red blood cells, indicating that these lumens were perfused ( Fig. for the ASC and 80% HUVEC/20% ASC constructs. Both the median values of the number of mouse vascular 6A, B).
The number of vascular lumens of mouse origin (lu-lumens/mm 2 and the total number of vascular lumens were significantly higher in 80% HUVEC/20% ASC mens not stained with CD31) and the total number of constructs when compared to ASC constructs [number Assessment of Lipid Accumulation in Spheroids Following Implantation in Nude Mice of mouse vascular lumens/mm 2 median: 17 (IQR: 14-17) vs. median: 0 (IQR: 0-6), p < 0.05; total number of vascular lumens median 38 (IQR: 35-47) vs. median: 0
To evaluate whether ASC in spheroid constructs also contained lipids after implantation, cross sections of re-(IQR: 0-6), p < 0.05]. trieved constructs were stained with Oil Red O. Similar derived stromal cells and endothelial cells for the purpose of prevascularization have been used before (16, to the in vitro cultures, Oil Red O-positive cells were evident in spheroid constructs (Fig. 7A) . 17, 27) . To our knowledge, however, this is the first study in which ASC are combined with HUVEC in a Vimentin staining of consecutive cross sections of the same spheroid constructs showed that Oil Red O-posi-spheroid coculture. We found that only spheroids seeded with a high (80%) percentage of HUVEC lead to the tive cells and vimentin-positive cells coincide in the same area, indicating that the Oil Red O-positive cells formation of prevascular structures. In contrast, Rouwkema et al. (27) showed that the formation of prevascu-were from human origin (Fig. 7B) . lar structures in HUVEC/bone marrow-derived stromal DISCUSSION cell (BMSC)/spheroid cocultures was positively affected by low (2%) percentages of HUVEC seeding. It is un-The present study demonstrates that our HUVEC/ ASC spheroid coculture system leads to the formation certain whether this difference is due to the use of ASC instead of BMSC, or the use of a different culture me-of prevascular structures while simultaneously enabling adipogenic differentiation of ASC in vitro, as indicated dium (endothelial/adipogenic mix medium instead of osteogenic medium). by the accumulation of lipid and the expression of FABP4. Moreover, our study shows that the prevascular Although HUVEC are an easily accessible source of endothelial cells, they will not be able to be used in structures within the implanted constructs are able to continue their development in vivo and can be incorpo-a clinical setting due to their incompatibility with the recipient's immune system. A potential alternative is the rated into the host vasculature, thereby contributing to the vascularization of the constructs.
use of microvascular endothelial cells derived from adipose tissue (13). Microvascular endothelial cells have After 7 days of implantation of the spheroids, we found that most of the 80% HUVEC/20% ASC spheroid already been demonstrated to be able to form vascular structures in cultured skin substitutes after implantation constructs contained human CD31 + vascular structures. These vascular structures regularly included lumen, in- (30) . In addition, endothelial progenitor cells derived from blood (22, 32) are a promising alternative. dicating stability and advanced development of the vascular structures in vivo. In contrast, ASC spheroid An optimal engineered tissue is assembled from multiple tissue-specific cells, has a typical tissue architec-constructs did not contain any human CD31 + vascular structures, demonstrating that the addition of HUVEC to ture and function, and supports a vasculature compatible with the native vascular system (15, 20,28). Endothelial ASC spheroids is necessary for the formation of human vascular structures in vivo.
cell/ASC spheroid constructs may be appropriate tissue units for engineering vascularized adipose tissue equiva-In vitro-formed vascular structures have been shown to be able to connect to host vessels upon implantation lents. We have shown that the ASC in our spheroid constructs obtain adipocyte-specific characteristics whereas (21, 23, 27, 31) . In our study, we observed red blood cells in a subset of human CD31 + stained lumina, indicating the HUVEC remain able to form prevascular structures that can integrate with the host (mouse) vasculature in a connection of the HUVEC-derived vascular structures with the mouse vasculature. In addition, we found a vivo. Spheroid constructs have also been shown to be able to form coherent macrotissue patches (mm 3 scale), higher total number of vascular lumens in cross sections of 80% HUVEC/20% ASC constructs when compared indicating that spheroid constructs can be scaled-up and used for the generation of larger sized tissue constructs to the total number of vascular lumens in ASC constructs. This higher total number of vascular lumens in (16) . Further studies should determine the in vivo survival of prevascularized adipose tissue constructs in the 80% HUVEC/20% ASC constructs is partly due to the presence of HUVEC-derived lumens, but also the result long term, as well as attempt to engineer thicker prevascularized adipose tissue equivalents. Potential strategies of a higher number of mouse-derived lumens, indicating augmented ingrowth of mouse vessels. This increased to produce prevascularized adipose tissue equivalents with clinically relevant dimensions could be the integra-ingrowth of host (mouse) vessels likely results from paracrine signaling induced by the implanted HUVEC/ASC tion of spheroid constructs with biomaterials such as photocross-linkable gels and advanced techniques such coculture spheroids. Taken together, these findings indicate that the in vitro formation of prevascular structures as microfluidics (18, 19) . in spheroid cultures can contribute to the development CONCLUSION of vascular structures in vivo. Such a contribution of in vitro prevascularization on in vivo vascularization has Based on our results, we conclude that a spheroid coculture of ASC with endothelial cells is suitable for also recently been shown in HUVEC/fibroblast fibrinbased cocultures by Chen et al. (6) .
the engineering of prevascularized adipose tissue constructs and that prevascularization improves the vascu-Spheroids composed of combinations of tissue- 
